CARGO Therapeutics, Inc. Common Stock
CRGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $7 | $4 | $1 | $0 |
| Gross Profit | -$7 | -$4 | -$1 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $143 | $76 | $29 | $4 |
| G&A Expenses | $44 | $21 | $5 | $2 |
| SG&A Expenses | $44 | $17 | $5 | $2 |
| Sales & Mktg Exp. | $0 | -$4 | $0 | $0 |
| Other Operating Expenses | -$7 | $0 | -$1 | -$0 |
| Operating Expenses | $180 | $93 | $33 | $6 |
| Operating Income | -$187 | -$97 | -$35 | -$6 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $20 | -$1 | -$6 | $0 |
| Pre-Tax Income | -$168 | -$98 | -$41 | -$6 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$168 | -$98 | -$41 | -$6 |
| % Margin | – | – | – | – |
| EPS | -3.72 | -2.38 | -2.13 | -0.3 |
| % Growth | -56.3% | -11.7% | -610% | – |
| EPS Diluted | -3.72 | -2.38 | -2.13 | -0.3 |
| Weighted Avg Shares Out | 45 | 41 | 19 | 19 |
| Weighted Avg Shares Out Dil | 45 | 41 | 19 | 19 |
| Supplemental Information | – | – | – | – |
| Interest Income | $20 | $0 | $0 | $0 |
| Interest Expense | $0 | $2 | $5 | $0 |
| Depreciation & Amortization | $7 | $4 | $1 | $0 |
| EBITDA | -$160 | -$93 | -$35 | -$6 |
| % Margin | – | – | – | – |